Ashland recently announced that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the calendar first quarter 2025, subject to the satisfaction of customary closing conditions.
US specialty chemicals producer Ashland has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions. Financial details of the transaction were not given.
US specialty chemicals producer Ashland has announced that it will start a divestiture process for the company’s nutraceuticals business.
French specialty chemicals company Arkema plans to acquire the 54% majority stake held by Glenwood Private Equity in South Korea-listed PI Advanced Materials (PIAM) for €728 million and fully consolidate the holding. The remaining 46% of equity will continue to be listed in South Korea.
US chemical producer Ashland is expanding its production and R&D site at the National Science Park in Mullingar, Ireland, which makes its Viatel-branded bioresorbable polymer. The upgrade, begun this summer, is expected to complete in 2024.
US specialty chemicals producer Ashland has announced it will undertake a strategic review of its performance adhesives business, which could include a potential sale.
US chemical producer Ashland said it has reached a “definitive agreement” to sell its maleic anhydride (MA) business and the production plant at Neal, West Virginia, to AOC Materials for $100 million. The transaction is expected to close by the end of 2020, pending all approvals.
